<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2990809/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Alzheimer Disease Pathology in Cognitively Healthy Elderly:A Genome-wide Study</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990809/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Neurobiology of aging"><meta name="citation_title" content="Alzheimer Disease Pathology in Cognitively Healthy Elderly:A Genome-wide Study"><meta name="citation_authors" content="Patricia L Kramer, Haiyan Xu, Randall L Woltjer, Shawn K Westaway, David Clark, Deniz Erten-Lyons, Jeffrey A Kaye, Kathleen A Welsh-Bohmer, Juan C Troncoso, William R Markesbery, Ronald C Petersen, R Scott Turner, Walter A Kukull, David A Bennett,  DouglasGalasko, John C Morris, Jurg Ott"><meta name="citation_date" content="December 2011"><meta name="citation_issue" content="12"><meta name="citation_volume" content="32"><meta name="citation_firstpage" content="2113"><meta name="citation_doi" content="10.1016/j.neurobiolaging.2010.01.010"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2990809/?report=abstract"><meta name="citation_pmid" content="20452100"><meta name="DC.Title" content="Alzheimer Disease Pathology in Cognitively Healthy Elderly:A Genome-wide Study"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Patricia L Kramer"><meta name="DC.Contributor" content="Haiyan Xu"><meta name="DC.Contributor" content="Randall L Woltjer"><meta name="DC.Contributor" content="Shawn K Westaway"><meta name="DC.Contributor" content="David Clark"><meta name="DC.Contributor" content="Deniz Erten-Lyons"><meta name="DC.Contributor" content="Jeffrey A Kaye"><meta name="DC.Contributor" content="Kathleen A Welsh-Bohmer"><meta name="DC.Contributor" content="Juan C Troncoso"><meta name="DC.Contributor" content="William R Markesbery"><meta name="DC.Contributor" content="Ronald C Petersen"><meta name="DC.Contributor" content="R Scott Turner"><meta name="DC.Contributor" content="Walter A Kukull"><meta name="DC.Contributor" content="David A Bennett"><meta name="DC.Contributor" content=" DouglasGalasko"><meta name="DC.Contributor" content="John C Morris"><meta name="DC.Contributor" content="Jurg Ott"><meta name="DC.Date" content="2011 Dec"><meta name="DC.Identifier" content="10.1016/j.neurobiolaging.2010.01.010"><meta name="DC.Language" content="en"><meta property="og:title" content="Alzheimer Disease Pathology in Cognitively Healthy Elderly:A Genome-wide Study"><meta property="og:type" content="article"><meta property="og:description" content="Many elderly individuals remain dementia-free throughout their life. However, some of these individuals exhibit Alzheimer disease neuropathology on autopsy, evidenced by neurofibrillary tangles (NFTs) in AD-specific brain regions. We conducted a genome-wide ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990809/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2990809/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2990809/pdf/nihms-222479.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8CD57ADD5066B10000000007A80527.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2990809%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="gquery">All Databases</option><option value="gene">Gene</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC2990809</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Neurobiol Aging</a></span>. Author manuscript; available in PMC 2012 Dec 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20452100" target="pmc_ext" ref="reftype=publisher&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Neurobiol Aging. 2011 Dec; 32(12): 2113–2122. </span></a></div><span class="fm-vol-iss-date">Published online 2010 May 7. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1016%2Fj.neurobiolaging.2010.01.010" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.neurobiolaging.2010.01.010</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2990809</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS222479</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20452100">20452100</a></div></div></div></div><h1 class="content-title">Alzheimer Disease Pathology in Cognitively Healthy Elderly:A Genome-wide Study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Kramer%20PL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923633914496" co-class="co-affbox">Patricia L Kramer</a>, PhD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Xu%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923627256976" co-class="co-affbox">Haiyan Xu</a>, PhD,<sup>5</sup> <a href="/pubmed/?term=Woltjer%20RL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923669970448" co-class="co-affbox">Randall L Woltjer</a>, MD, PhD,<sup>3</sup> <a href="/pubmed/?term=Westaway%20SK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923628033008" co-class="co-affbox">Shawn K Westaway</a>, PhD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Clark%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923632080768" co-class="co-affbox">David Clark</a>,<sup>3</sup> <a href="/pubmed/?term=Erten-Lyons%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923632078544" co-class="co-affbox">Deniz Erten-Lyons</a>, MD,<sup>1</sup> <a href="/pubmed/?term=Kaye%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923661095632" co-class="co-affbox">Jeffrey A Kaye</a>, MD,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Welsh-Bohmer%20KA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923627984928" co-class="co-affbox">Kathleen A Welsh-Bohmer</a>, PhD,<sup>6</sup> <a href="/pubmed/?term=Troncoso%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923627982448" co-class="co-affbox">Juan C Troncoso</a>, MD,<sup>7</sup> <a href="/pubmed/?term=Markesbery%20WR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923630327056" co-class="co-affbox">William R Markesbery</a>, MD,<sup>8</sup> <a href="/pubmed/?term=Petersen%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923632643104" co-class="co-affbox">Ronald C Petersen</a>, MD, PhD,<sup>9</sup> <a href="/pubmed/?term=Turner%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923702744288" co-class="co-affbox">R Scott Turner</a>, MD, PhD,<sup>10</sup> <a href="/pubmed/?term=Kukull%20WA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923624837264" co-class="co-affbox">Walter A Kukull</a>, PhD,<sup>11</sup> <a href="/pubmed/?term=Bennett%20DA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923636588832" co-class="co-affbox">David A Bennett</a>, MD,<sup>12</sup> <a href="/pubmed/?term=DouglasGalasko%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923634769072" co-class="co-affbox"> DouglasGalasko</a>, MD,<sup>13</sup> <a href="/pubmed/?term=Morris%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923633889760" co-class="co-affbox">John C Morris</a>, MD,<sup>14</sup> and  <a href="/pubmed/?term=Ott%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100" class="affpopup" co-rid="_co_idm139923631609584" co-class="co-affbox">Jurg Ott</a>, PhD<sup>15</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139923633914496"><h3 class="no_margin">Patricia L Kramer</h3><p><sup>1</sup>Department of Neurology, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><p><sup>2</sup>Department of Molecular and Medical Genetics, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><div>Find articles by <a href="/pubmed/?term=Kramer%20PL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Patricia L Kramer</a></div></div><div id="_co_idm139923627256976"><h3 class="no_margin">Haiyan Xu</h3><p><sup>5</sup>Laboratory of Statistical Genetics, Rockefeller University, New York NY, 10065, USA</p><div>Find articles by <a href="/pubmed/?term=Xu%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Haiyan Xu</a></div></div><div id="_co_idm139923669970448"><h3 class="no_margin">Randall L Woltjer</h3><p><sup>3</sup>Department of Pathology, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><div>Find articles by <a href="/pubmed/?term=Woltjer%20RL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Randall L Woltjer</a></div></div><div id="_co_idm139923628033008"><h3 class="no_margin">Shawn K Westaway</h3><p><sup>1</sup>Department of Neurology, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><p><sup>2</sup>Department of Molecular and Medical Genetics, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><div>Find articles by <a href="/pubmed/?term=Westaway%20SK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Shawn K Westaway</a></div></div><div id="_co_idm139923632080768"><h3 class="no_margin">David Clark</h3><p><sup>3</sup>Department of Pathology, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><div>Find articles by <a href="/pubmed/?term=Clark%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">David Clark</a></div></div><div id="_co_idm139923632078544"><h3 class="no_margin">Deniz Erten-Lyons</h3><p><sup>1</sup>Department of Neurology, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><div>Find articles by <a href="/pubmed/?term=Erten-Lyons%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Deniz Erten-Lyons</a></div></div><div id="_co_idm139923661095632"><h3 class="no_margin">Jeffrey A Kaye</h3><p><sup>1</sup>Department of Neurology, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><p><sup>4</sup>Department of Biomedical Engineering, Oregon Health&amp; Science University, Portland OR, 97239, USA</p><div>Find articles by <a href="/pubmed/?term=Kaye%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Jeffrey A Kaye</a></div></div><div id="_co_idm139923627984928"><h3 class="no_margin">Kathleen A Welsh-Bohmer</h3><p><sup>6</sup>Departments of Psychiatry and Medicine (Neurology)/Duke University Medical Center, Durham NC, 27710, USA</p><div>Find articles by <a href="/pubmed/?term=Welsh-Bohmer%20KA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Kathleen A Welsh-Bohmer</a></div></div><div id="_co_idm139923627982448"><h3 class="no_margin">Juan C Troncoso</h3><p><sup>7</sup> Departments of Pathology and Neurology, Johns Hopkins University, Baltimore MD, 21205</p><div>Find articles by <a href="/pubmed/?term=Troncoso%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Juan C Troncoso</a></div></div><div id="_co_idm139923630327056"><h3 class="no_margin">William R Markesbery</h3><p><sup>8</sup>Departments of Pathology and Neurology, University of Kentucky, Lexington KY, 40536, USA</p><div>Find articles by <a href="/pubmed/?term=Markesbery%20WR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">William R Markesbery</a></div></div><div id="_co_idm139923632643104"><h3 class="no_margin">Ronald C Petersen</h3><p><sup>9</sup>Department of Neurology, Mayo Clinic, Rochester MN 55905, USA</p><div>Find articles by <a href="/pubmed/?term=Petersen%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Ronald C Petersen</a></div></div><div id="_co_idm139923702744288"><h3 class="no_margin">R Scott Turner</h3><p><sup>10</sup> Department of Neurology, University of Michigan, Ann Arbor MI, 48105, and Georgetown University Medical Center, Washington DC, 20057, USA</p><div>Find articles by <a href="/pubmed/?term=Turner%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">R Scott Turner</a></div></div><div id="_co_idm139923624837264"><h3 class="no_margin">Walter A Kukull</h3><p><sup>11</sup> National Alzheimer Coordinating Center and Department of Epidemiology, Seattle WA, 98105</p><div>Find articles by <a href="/pubmed/?term=Kukull%20WA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Walter A Kukull</a></div></div><div id="_co_idm139923636588832"><h3 class="no_margin">David A Bennett</h3><p><sup>12</sup>Rush University Medical Center, Chicago IL, 60612, USA</p><div>Find articles by <a href="/pubmed/?term=Bennett%20DA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">David A Bennett</a></div></div><div id="_co_idm139923634769072"><h3 class="no_margin"> DouglasGalasko</h3><p><sup>13</sup>Department of Neurosciences, University of California at San Diego, San Diego CA 92037</p><div>Find articles by <a href="/pubmed/?term=DouglasGalasko%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100"> DouglasGalasko</a></div></div><div id="_co_idm139923633889760"><h3 class="no_margin">John C Morris</h3><p><sup>14</sup>Department of Neurology, Washington University School of Medicine, St. Louis MO, 63108</p><div>Find articles by <a href="/pubmed/?term=Morris%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">John C Morris</a></div></div><div id="_co_idm139923631609584"><h3 class="no_margin">Jurg Ott</h3><p><sup>15</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100029, China</p><div>Find articles by <a href="/pubmed/?term=Ott%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20452100">Jurg Ott</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139923661133312_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139923661133312_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139923661133312_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Department of Neurology, Oregon Health&amp; Science University, Portland OR, 97239, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Department of Molecular and Medical Genetics, Oregon Health&amp; Science University, Portland OR, 97239, USA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Department of Pathology, Oregon Health&amp; Science University, Portland OR, 97239, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Biomedical Engineering, Oregon Health&amp; Science University, Portland OR, 97239, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Laboratory of Statistical Genetics, Rockefeller University, New York NY, 10065, USA</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Departments of Psychiatry and Medicine (Neurology)/Duke University Medical Center, Durham NC, 27710, USA</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup> Departments of Pathology and Neurology, Johns Hopkins University, Baltimore MD, 21205</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Departments of Pathology and Neurology, University of Kentucky, Lexington KY, 40536, USA</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Department of Neurology, Mayo Clinic, Rochester MN 55905, USA</div><div class="fm-affl" id="A10" lang="en"><sup>10</sup> Department of Neurology, University of Michigan, Ann Arbor MI, 48105, and Georgetown University Medical Center, Washington DC, 20057, USA</div><div class="fm-affl" id="A11" lang="en"><sup>11</sup> National Alzheimer Coordinating Center and Department of Epidemiology, Seattle WA, 98105</div><div class="fm-affl" id="A12" lang="en"><sup>12</sup>Rush University Medical Center, Chicago IL, 60612, USA</div><div class="fm-affl" id="A13" lang="en"><sup>13</sup>Department of Neurosciences, University of California at San Diego, San Diego CA 92037</div><div class="fm-affl" id="A14" lang="en"><sup>14</sup>Department of Neurology, Washington University School of Medicine, St. Louis MO, 63108</div><div class="fm-affl" id="A15" lang="en"><sup>15</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100029, China</div><div id="CR1"><span class="underline">Corresponding author</span>: Patricia L. Kramer, PhD Department of Neurology CR131 Oregon Health &amp; Science University Portland, OR 97239 503-494-7196 (phone) 503-494-7499 (fax) <a href="mailto:dev@null" data-email="ude.usho@remark" class="oemail">ude.usho@remark</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139923661133312_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20452100" target="pmc_ext" ref="reftype=publisher&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Neurobiol Aging</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC2990809/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="idm139923633529376" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139923633529376title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Many elderly individuals remain dementia-free throughout their life. However, some of these individuals exhibit Alzheimer disease neuropathology on autopsy, evidenced by neurofibrillary tangles (NFTs) in AD-specific brain regions. We conducted a genome-wide association study to identify genetic mechanisms that distinguish non-demented elderly with a heavy NFT burden from those with a low NFT burden. The study included 344 non-demented subjects with autopsy (201 subjects with low and 143 with high NFT levels). Both a genotype test, using logistic regression, and an allele test provided genome-wide significant evidence that variants in the <em>RELN</em>gene are associated with neuropathology in the context of cognitive health. Immunohistochemical data for reelin expression in AD-related brain regions added support for these findings. Reelin signaling pathways modulate phosphorylation of tau, the major component of NFTs, either directly or through β-amyloid pathways that influence tau phosphorylation. Our findings suggest that up-regulation of reelin may be a compensatory response to tau-related or beta-amyloid stress associated with AD even prior to the onset of dementia.</p></div></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">1. INTRODUCTION</h2><p id="P2" class="p p-first">Prevalence rates for Alzheimer disease (AD) climb steadily from ~1% in 65-year-olds to as high as 40% by the age of 85[<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851378">Hebert, et al. 2003</a>]. Despite these dire figures, some elderly individuals remain dementia-free throughout their life and, of these, a proportion exhibit substantial AD neuropathology, in the form of amyloid plaques and neurofibrillary tangles (NFTs),at autopsy [<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851373">Erten-Lyons, et al. 2009</a>], [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851384">Bennett, et al. 2005</a>].Thus, individuals differ in their capacity to maintain normative cognitive function even within the context of neuropathological structural changes associated with AD.</p><p id="P3">There are a number of ways in which genetic mechanisms might promote cognitive health. On one hand, genetic variants may prevent development of the neuropathological substrate that underlies susceptibility to cognitive dysfunction. Alternatively, in the presence of neuropathology, genetic variants may mitigate the effects of AD-related lesions that otherwise result in cognitive decline. The first case provides greater guarantee of cognitive health. Thus, it is important to identify genetic variants associated with development of AD neuropathology within the context of cognitive resilience.</p><p id="P4" class="p p-last">We conducted a genome-wide SNP association study (GWAS) to identify genetic mechanisms involved in healthy brain aging. This study was based on a sample of non-demented, deceased subjects with autopsy who were members of longitudinal healthy aging cohorts at 10 NIA-funded Alzheimer Disease Centers (ADC). These subjects comprised one group with little or no evidence of NFT formation, and one with substantial or severe levels of NFT formation in critical brain regions. We report results that implicate variants in the glycoprotein reelin (<em>RELN</em>)as key elements in the molecular basis of AD-related neuropathological processes. We provide additional support for these statistical findings with immunohistochemical data for reelin expression in AD-related brain regions in a subset of our study subjects. To our knowledge, this is the first GWAS that specifically addresses genetic mechanisms of AD neuropathology in non-demented elderly with post-mortem examinations.</p></div><div id="S2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">2. Methods</h2><div id="S3" class="sec sec-first"><h3 id="S3title">2.1 Subjects</h3><p id="P5" class="p p-first-last">Subjects were recruited from aging research cohorts collected over the last two decades at 10 NIA-funded ADCs across the country. Eligibility criteria included the following: 1) ≥65 years old at enrollment; 2) deceased, with autopsy; 3) clinical diagnosis of “no dementia” at enrollment and death; 4) ≥1 clinical evaluation within the year before death; 5) DNA available; 6) Caucasian ancestry. A total of 412 subjects met initial criteria. All subjects had been previously genotyped for apolipoproteinE (<em>APOE )</em> status and these data were provided by the respective ADC Data Cores. The study was approved by the IRB at OHSU.</p></div><div id="S4" class="sec"><h3 id="S4title">2.2 Neuropathologic Diagnosis</h3><p id="P6" class="p p-first">One of the hallmarks of AD is the occurrence of NFTs in limbic and neocortical regions of the brain. The Braak score[<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851362">Braak and Braak 1991</a>] is a measure of the location and frequency of NFTs and is key to establishing the pathologic diagnosis of AD[<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851386">1997</a>]. Braak scores (BS) range from 0 (no NFTs) to 6 (NFTs in primary motor and/or sensory neocortex), and were obtained for all subjects from the ADC Clinical Data Cores.</p><p id="P7">We classified subjects on the basis of NFT burden to obtain subsets of individuals for analysis. Autopsy reports were reviewed for consistency with the Braak score provided in the data files from each ADC by a 3-member team including a neuropathologist (RW), a neurologist (JK) and a geneticist (PK). Subjects were classified into three groups: LOBraak (≤2), MEDBraak and HIBraak (≥4):
</p><ol class="enumerated" style="list-style-type:decimal" id="L1"><!--
list-behavior=enumerated
prefix-word=
mark-type=decimal
max-label-size=0
--><li><p id="P8">If the Braak score and information in the autopsy report were consistent with low NFT levels, the subject was classified as LOBraak (n=189).</p></li><li><p id="P9">If the Braak score and information in the autopsy were consistent with high NFT levels, the subject was classified as HIBraak (n=110).</p></li><li><p id="P10">If the Braak score and autopsy information were at odds with respect to classification of LO or HI NFT burden, preference was given to the autopsy (n=12).</p></li><li><p id="P11">If the Braak score and autopsy information agreed with a Braak score of 3, the subjects was classified as MEDBraak (n= 80); furthermore, if the BS was 2, 3 or 4, but the autopsy report lacked sufficient detail to confirm these scores, the subject was also classified as MEDBraak (n=21).In order to maximize phenotypic homogeneity between groups, and thus increase power, we excluded this group from the initial analysis.</p></li></ol><p></p><p id="P12" class="p p-last">The final sample consisted of 311 subjects (192 LOBraak, 119HIBraak).</p></div><div id="S5" class="sec"><h3 id="S5title">2.3 Clinical Diagnosis</h3><p id="P13" class="p p-first">All study subjects were deceased and had been evaluated for cognitive decline and dementia within 12 months prior to death. Assessments for determining absence of dementia were consistent with standardized protocols in the DSM-III-R.</p><p id="P14">To minimize the extent of any cognitive impairment in the two groups, we obtained longitudinal clinical data for all subjects, consisting of Clinical Dementia Rating (CDR) scores[<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851381">Morris 1993</a>] and/or Mini-Mental State Exam (MMSE) scores[<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851361">Folstein, et al. 1975</a>], from the time of enrollment until death. The CDR is a dementia staging-tool in which a score of 0 represents no cognitive impairment, .5 may represent some cognitive impairment, and a score≥1 represents dementia; MMSE scores≥26are generally indicative of no dementia.</p><p id="P15" class="p p-last">Longitudinal CDR scores were available for 143 of the 311 subjects. Of these, 120 (84%) had no CDR scores&gt;0; 23(16%) had one CDR of .5 at some point during participation. Among these 23, 15 were in the LO Braak and 8 in the HIBraak group. In the majority of these 23 subjects – 11 in the LO and 5 in the HI Braak group – the CDR of .5 occurred at some point prior to the last evaluation and was followed by CDRs of 0 in subsequent evaluations. Longitudinal MMSE scores were available for the remaining 168 subjects. All had MMSE ≥ 26 at death (mean = 28.3; sd = 1.3).</p></div><div id="S6" class="sec"><h3 id="S6title">2.4 Genotyping</h3><p id="P16" class="p p-first">DNA was extracted from blood in 91 of the 311 subjects, using standard procedures. For the remaining 220 subjects, DNA was extracted from frozen brain tissue. Genomic DNA was extracted from 100 mg of brain tissue using the Wizard Genomic DNA Purification Kit according to the manufacturer (Promega,Inc.). DNA quality and concentration were determined using a Biomate-3 spectrophotometer.</p><p id="P17" class="p p-last">Genotyping was performed by deCODE Genetics (Reykjavik, Iceland). Genotypes were obtained using the Illumina HumanCNV370v1_C array from 750 ng of genomic DNA following manufacturer's protocols (Illumina, Inc.). Illumina's BeadStudio3.1.14 genotyping module was used to cluster, call genotypes, and assign confidence scores.</p></div><div id="S7" class="sec sec-last"><h3 id="S7title">2.5 Analysis</h3><div id="S8" class="sec sec-first"><p></p><h4 id="S8title" class="inline">2.5.1Quality Control </h4><p id="P18" class="p p-first-last">We included only individuals with a missing genotype rate &lt; 20%. Specifically, three individuals had missing rates of 19, 18 and 16%, and all others had rates &lt; 2%. Since SNPs with low call rates may inflate association statistics [<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851385">Plenge, et al. 2007</a>], only autosomal SNPs (n=334,221) with call rates ≥ 99% across the entire sample were used (21387 SNPs excluded due to low call rates). Only SNPs with a minor allele frequency (MAF) &gt; 0.05 in cases and controls were included (20,730 SNPs excluded for low MAF). We also required absence of strong deviation from Hardy-Weinberg equilibrium (HWE) in controls; specifically, likelihood ratio χ<sup>2</sup>&lt; 50, corresponding to a nominal p-value of 1.54 × 10<sup>-12.</sup> This threshold was chosen so that SNPs with only the most extreme deviations from HWE would be deleted (30 SNPs excluded for deviation from HWE). As a result of these quality control measures, a total of 292,074 SNPs were used in this analysis.</p></div><div id="S9" class="sec"><p></p><h4 id="S9title" class="inline">2.5.2 Association Analysis </h4><p id="P19" class="p p-first">Two different methods were used to test for the association between SNPs and the phenotype --association at the genotype and at the allele level. The former was carried out via logistic regression analysis with covariates and the latter with the Set Association approach[<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851367">Hoh, et al. 2001</a>] without covariates. We tested the effect of putative non-genetic risk factors on the phenotype, and found that sex and age-at-death had a significant impact. Thus in the logistic regression approach, genotypes at a given SNP (a categorical variable), sex (a categorical variable) and age of death (a continuous variable) were included as independent variables, and the Braak score category, HI (“case”) vs. LO (“control”), as the dependent variable. The fitting of a general linear model (binomial family in this case) was conducted in R (<a href="http://cran.cnr.berkeley.edu/web/packages/qvalue/index.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://cran.cnr.berkeley.edu/web/packages/qvalue/index.html</a>). For the two degrees of freedom associated with the genotypes at a given SNP, logistic regression furnished two p-values. To obtain a single significance level for one variant, these two (independent) p-values were combined into one with the unweighted Z transform method[<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851375">Whitlock 2005</a>].</p><p id="P20" class="p p-last">We chose agenotypic model because it is a general model, and is sensitive to different types of association. It is also ideally suited for logistic regression analysis, in which we allow for the total effects of genotypes and non-genetic factors, the latter of which act on individuals (i.e., genotypes) rather than alleles. Since the logistic regression result is most robust when all three possible genotypes are represented in both comparison groups, we only included SNPs in which this was the case; of the 292,074 SNPs which passed quality control measures described above, 12,163 were excluded because there were &lt; 3 genotype classes in the HI Braak and/or LO Braak groups. Thus, the total number of SNPs in the logistic regression analysis was 279,911. To assess the association of SNP alleles with our phenotype, we initially carried out 1 df chi-square tests in 2 × 2 tables of alleles for each of the 279,911 SNPs and constructed a Q-Q plot for the resulting chi-square values using the Systat 12 statistics package (<a href="http://www.systat.com/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.systat.com/</a>).In Set Association analysis[<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851379">Hoh, et al. 2001</a>], we evaluated the combined effects of multiple SNPs. The combined association of a given number of SNPs (wherever they are in the genome) was measured by the sum of their corresponding test statistics (1 df chi-squares). We focused on the most significant <em>m</em> SNPs, with <em>m</em> ranging successively from 1 through 15. Significance levels for each such sum were evaluated with permutation analysis, and the smallest p-value for these sums was taken as the genome-wide test statistic, whose significance level was again evaluated in randomization samples. This approach represents an approximation to multivariate analysis[<a href="#R16" rid="R16" class=" bibr popnode">Manly 2007</a>] and, thus, assesses the joint effects of the most significant SNPs on disease association. In this analysis, the <em>sumstat</em> program was used with 20,000 randomization samples per run (<a href="http://linkage.rockefeller.edu/ott/sumstat.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://linkage.rockefeller.edu/ott/sumstat.html</a>).</p></div><div id="S10" class="sec"><p></p><h4 id="S10title" class="inline">2.5.3 Population Stratification </h4><p id="P21" class="p p-first-last">We used the agglomerative clustering method based on identity by state (IBS), as implemented in PLINK v1.05[<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851380">Purcell, et al. 2007</a>] (<a href="http://pngu.mgh.harvard.edu/~purcell/plink/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://pngu.mgh.harvard.edu/~purcell/plink/</a>) to test for population stratification in our data.</p></div><div id="S11" class="sec"><p></p><h4 id="S11title" class="inline">2.5.4 Post-hoc Analysis </h4><p id="P22" class="p p-first-last">For particular SNPs of interest, we conducted a post-hoc analysis in which allelic association to the phenotype was tested with a likelihood ratio(LR) chi-square test, and the odds ratio(OR) was calculated with a 95% confidence interval (CI).</p></div><div id="S12" class="sec sec-last"><p></p><h4 id="S12title" class="inline">2.5.6 Immunohistochemistry </h4><p id="P23" class="p p-first-last">Immunohistochemistry for reelin expression was performed on cases with autopsy performed at OHSU and for which the postmortem interval was less than 24 hours. Brains were fixed in neutral-buffered formaldehyde solution for at least 2 weeks and fixed hippocampal sections were processed in paraffin 7-μm sections, deparaffinized, subjected to standard antigen retrieval techniques (5 minute treatment at room temperature with 95% formic acid, followed by incubation at 85-90 °C in citrate buffer, pH 6.0 for 30 min) and stained with antibody to reelin (Santa Cruz Biotechnology, Santa Cruz, CA, antibody H221 used at 1:200 dilution). Sections were developed using the Vectastain ABC technique (Vector Laboratories, Burlingame, CA). Reelin staining of pyramidal neurons was evaluated in CA1-4 regions of the hippocampus and in subiculum by a neuropathologist (RLW) who was blinded to case status. A semiquantitative score was assigned to reelin positivity in pyramidal neurons in each hippocampal sector (0=no detectable reelin staining, 1=cytoplasmic blush staining detectable at 40x magnification, 2=clear cytoplasmic staining identifiable at 10x magnification, 3=pyramidal neurons identified as strong band of cytoplasmic staining visible at 4x magnification. Total reelin staining was calculated as the sum of the score in each region of hippocampus.</p></div></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">3. Results</h2><div id="S14" class="sec sec-first"><h3 id="S14title">3.1 Sample Characteristics</h3><p id="P24" class="p p-first">Sample characteristics of the two groups are provided in <a href="/pmc/articles/PMC2990809/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. The proportion of females is increased in the HIBraak group, and the difference is significant (p=0.019). Subjects in the HIBraak category were significantly older at death than those in the LOBraak group (p&lt;.0001); thus, we incorporated both gender and age-at-death as covariates. <em>APOE</em> allele frequencies(based on pre-determined <em>APOE</em> genotypes) did not differ significantly between groups (p=.556), nor did education level (p=.544).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p6">Sample Characteristics</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923636369856" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="center">LO Braak (n=192) # (%)</th><th rowspan="1" colspan="1" valign="top" align="center">HI Braak (n=119) # (%)</th><th rowspan="1" colspan="1" valign="top" align="left">p-value</th></tr></thead><tbody><tr><td rowspan="2" colspan="1" valign="top" align="left">Sex:</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>male</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">98 (51%)</td><td rowspan="1" colspan="1" valign="top" align="center">44 (37%)</td><td rowspan="1" colspan="1" valign="top" align="left">.019</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>female</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">94 (49%)</td><td rowspan="1" colspan="1" valign="top" align="center">75 (63%)</td><td rowspan="1" colspan="1" valign="top" align="left">Fisher's exact, 2-tailed</td></tr><tr><td colspan="5" rowspan="1" valign="top" align="center"><hr></td></tr><tr><td rowspan="2" colspan="1" valign="top" align="left">Age at Death: (years)</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>mean (sd)</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">83.83 (7.62)</td><td rowspan="1" colspan="1" valign="top" align="center">87.77 (6.12)</td><td rowspan="1" colspan="1" valign="top" align="left">&lt; .0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>range</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">65-104</td><td rowspan="1" colspan="1" valign="top" align="center">72-106</td><td rowspan="1" colspan="1" valign="top" align="left">t-test</td></tr><tr><td colspan="5" rowspan="1" valign="top" align="center"><hr></td></tr><tr><td rowspan="2" colspan="1" valign="top" align="left">Education: (years)</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>mean(sd)</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">17.08 (3.88)</td><td rowspan="1" colspan="1" valign="top" align="center">17.30 (3.80)</td><td rowspan="1" colspan="1" valign="top" align="left">.544</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>range</em>
</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="left">t-test</td></tr><tr><td colspan="5" rowspan="1" valign="top" align="center"><hr></td></tr><tr><td rowspan="3" colspan="1" valign="top" align="left">APOE allele frequency n (%)</td><td rowspan="1" colspan="1" valign="top" align="left">ε2</td><td rowspan="1" colspan="1" valign="top" align="center">38 (10%)</td><td rowspan="1" colspan="1" valign="top" align="center">23 (10%)</td><td rowspan="1" colspan="1" valign="top" align="left">.556</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">ε3</td><td rowspan="1" colspan="1" valign="top" align="center">299(80%)</td><td rowspan="1" colspan="1" valign="top" align="center">180 (77%)</td><td rowspan="1" colspan="1" valign="top" align="left">χ<sup>2</sup> = 1.17,2 <em>df</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">ε4</td><td rowspan="1" colspan="1" valign="top" align="center">39 (10%)</td><td rowspan="1" colspan="1" valign="top" align="center">31(13%)</td><td rowspan="1" colspan="1" valign="top" align="left"></td></tr><tr><td colspan="5" rowspan="1" valign="top" align="center"><hr></td></tr><tr><td rowspan="4" colspan="1" valign="top" align="left">Neuritic plaque density:</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>frequent</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">9 (5%)</td><td rowspan="1" colspan="1" valign="top" align="center">31(26%)</td><td rowspan="1" colspan="1" valign="top" align="left">&lt; .001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>moderate</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">44 (23%)</td><td rowspan="1" colspan="1" valign="top" align="center">50 (42%)</td><td rowspan="1" colspan="1" valign="top" align="left">χ<sup>2</sup> = 58.1, 3<em>df</em></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>sparse</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">40 (21%)</td><td rowspan="1" colspan="1" valign="top" align="center">16 (14%)</td><td rowspan="1" colspan="1" valign="top" align="left"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>none</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">97 (51%)</td><td rowspan="1" colspan="1" valign="top" align="center">21 (18%)</td><td rowspan="1" colspan="1" valign="top" align="left"></td></tr></tbody></table></div><div id="largeobj_idm139923636369856" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2990809/table/T1/?report=objectonly">Open in a separate window</a></div></div><p id="P25" class="p p-last">The distribution of neuritic plaque density was different between groups (p&lt;0.0001). Only 28% of subjects in the LOBraak category had “frequent” or “moderate” plaques, compared to 68% in the HI category. Hence, although Braak score was used to stratify groups by AD-associated neuropathological features, stratification by neuritic plaque burden also occurred.</p></div><div id="S15" class="sec"><h3 id="S15title">3.2 Analysis</h3><p id="P26" class="p p-first">Results of the test for population stratification indicated that all subjects were assigned to the same cluster, and there was no significant difference between pair-wise IBS distances in the LO and HI Braak groups. Thus, we detected no evidence for population stratification.</p><p id="P27">Allelic association for one SNP at a time resulted in one SNP, <em>rs4298437</em> on chromosome 7, showing a Bonferroni-corrected significance level of p = 0.0341. Results for the ten SNPs with lowest p-values are shown in <a href="/pmc/articles/PMC2990809/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>. The Q-Q plot in <a href="/pmc/articles/PMC2990809/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a> for all 279,911 SNPs demonstrates that most of the chi-square values perfectly follow theoretically expected values, thus confirming the conclusion of absence of population stratification. The plot also shows that at least ten SNPs have elevated test statistics.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2990809/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923635149760" class="figure"><a href="/pmc/articles/PMC2990809/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2990809_nihms-222479-f0001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-222479-f0001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2990809/bin/nihms-222479-f0001.jpg"></a></div><div id="largeobj_idm139923635149760" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2990809/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2990809/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p2">Q-Q plot based on nominal p-values resulting from the allelic association test</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p7">Results of the allele association tests, showing the ten best SNPs, listed in order of significance</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923628532464" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">Rank</th><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="left">Chr</th><th rowspan="1" colspan="1" valign="top" align="left">Position</th><th rowspan="1" colspan="1" valign="top" align="left">Chi-square</th><th rowspan="1" colspan="1" valign="top" align="center">pNom<sup>1</sup></th><th rowspan="1" colspan="1" valign="top" align="center">pBon<sup>2</sup></th><th rowspan="1" colspan="1" valign="top" align="center">pRand<sup>3</sup></th><th rowspan="1" colspan="1" valign="top" align="center">pSum<sup>4</sup></th><th rowspan="1" colspan="1" valign="top" align="left">Gene<sup>5</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">1</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs4298437</em>
<sup>*</sup>
</td><td rowspan="1" colspan="1" valign="top" align="left">7</td><td rowspan="1" colspan="1" valign="top" align="left">103413113</td><td rowspan="1" colspan="1" valign="top" align="left">27.9567</td><td rowspan="1" colspan="1" valign="top" align="center">1.241E-07</td><td rowspan="1" colspan="1" valign="top" align="center">0.0341</td><td rowspan="1" colspan="1" valign="top" align="center">0.0354</td><td rowspan="1" colspan="1" valign="top" align="center">0.0354</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>RELN</em>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">2</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs11782819</em>
<sup>*</sup>
</td><td rowspan="1" colspan="1" valign="top" align="left">8</td><td rowspan="1" colspan="1" valign="top" align="left">10372191</td><td rowspan="1" colspan="1" valign="top" align="left">22.5979</td><td rowspan="1" colspan="1" valign="top" align="center">1.997E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.4282</td><td rowspan="1" colspan="1" valign="top" align="center">0.4086</td><td rowspan="1" colspan="1" valign="top" align="center">0.0538</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>UNQ9391</em>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">3</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs6943822</em>
<sup>*</sup>
</td><td rowspan="1" colspan="1" valign="top" align="left">7</td><td rowspan="1" colspan="1" valign="top" align="left">103385907</td><td rowspan="1" colspan="1" valign="top" align="left">22.4898</td><td rowspan="1" colspan="1" valign="top" align="center">2.113E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.4464</td><td rowspan="1" colspan="1" valign="top" align="center">0.4263</td><td rowspan="1" colspan="1" valign="top" align="center">0.0463</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>RELN</em>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">4</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs3791523</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">2</td><td rowspan="1" colspan="1" valign="top" align="left">239753412</td><td rowspan="1" colspan="1" valign="top" align="left">22.4401</td><td rowspan="1" colspan="1" valign="top" align="center">2.168E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.4549</td><td rowspan="1" colspan="1" valign="top" align="center">0.4337</td><td rowspan="1" colspan="1" valign="top" align="center">0.0355</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>HDAC4</em>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">5</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs1481650</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">8</td><td rowspan="1" colspan="1" valign="top" align="left">26829428</td><td rowspan="1" colspan="1" valign="top" align="left">21.8844</td><td rowspan="1" colspan="1" valign="top" align="center">2.896E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.5554</td><td rowspan="1" colspan="1" valign="top" align="center">0.5347</td><td rowspan="1" colspan="1" valign="top" align="center">0.0288</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>ADRA1A</em>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">6</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs6734151</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">2</td><td rowspan="1" colspan="1" valign="top" align="left">5387284</td><td rowspan="1" colspan="1" valign="top" align="left">20.0985</td><td rowspan="1" colspan="1" valign="top" align="center">7.355E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.8724</td><td rowspan="1" colspan="1" valign="top" align="center">0.8510</td><td rowspan="1" colspan="1" valign="top" align="center">0.0284</td><td rowspan="1" colspan="1" valign="top" align="left">unknown</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">7</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs10956170</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">8</td><td rowspan="1" colspan="1" valign="top" align="left">125381841</td><td rowspan="1" colspan="1" valign="top" align="left">19.7785</td><td rowspan="1" colspan="1" valign="top" align="center">8.695E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.9123</td><td rowspan="1" colspan="1" valign="top" align="center">0.8897</td><td rowspan="1" colspan="1" valign="top" align="center">0.0280</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>TMEM65</em>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">8</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs894520</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">9</td><td rowspan="1" colspan="1" valign="top" align="left">38179527</td><td rowspan="1" colspan="1" valign="top" align="left">19.5413</td><td rowspan="1" colspan="1" valign="top" align="center">9.845E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.9364</td><td rowspan="1" colspan="1" valign="top" align="center">0.9185</td><td rowspan="1" colspan="1" valign="top" align="center">0.0273</td><td rowspan="1" colspan="1" valign="top" align="left">unknown</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">9</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs9530579</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">13</td><td rowspan="1" colspan="1" valign="top" align="left">76123603</td><td rowspan="1" colspan="1" valign="top" align="left">18.7333</td><td rowspan="1" colspan="1" valign="top" align="center">1.503E-05</td><td rowspan="1" colspan="1" valign="top" align="center">0.9851</td><td rowspan="1" colspan="1" valign="top" align="center">0.9768</td><td rowspan="1" colspan="1" valign="top" align="center">0.0284</td><td rowspan="1" colspan="1" valign="top" align="left">unknown</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">10</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs4790069</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">17</td><td rowspan="1" colspan="1" valign="top" align="left">74561296</td><td rowspan="1" colspan="1" valign="top" align="left">18.593</td><td rowspan="1" colspan="1" valign="top" align="center">1.618E-05</td><td rowspan="1" colspan="1" valign="top" align="center">0.9892</td><td rowspan="1" colspan="1" valign="top" align="center">0.9825</td><td rowspan="1" colspan="1" valign="top" align="center">0.0285</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>C1QTNF1</em>
</td></tr></tbody></table></div><div id="largeobj_idm139923628532464" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2990809/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>*</sup>gene (in which SNP is located) appears also in the list of significant genes obtained in the logistic regression analysis (<a href="/pmc/articles/PMC2990809/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>): <em>RELN</em> (<em>rs4298437</em> and <em>rs6943822)</em> and <em>UNQ9391</em> (<em>rs11782819</em>)</div><div id="TFN2"><sup>1</sup>pNom = nominal p-value</div><div id="TFN3"><sup>2</sup>pBon = Bonferroni-corrected p-value (n = 279,911 SNPs)</div><div id="TFN4"><sup>3</sup>pRand = p-value computed in 20,000 randomization samples</div><div id="TFN5"><sup>4</sup>pSum = p-value associated with chi-square values summed up to given rank</div><div id="TFN6"><sup>5</sup>data from NCBI MapViewer Buuild 36.3 (<a href="http://www.ncbi.nlm.nih.gov/mapview/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/mapview/</a>)</div></div></div><p id="P28">In the Set Association analysis, the sum of chi-squares for SNPs (<a href="/pmc/articles/PMC2990809/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>; pSum) ranked 1-8 exhibited the smallest significance level, p<sub>min</sub> = 0.0273. This analysis indicated that approximately eight SNPs jointly contribute to AD neuropathology although this conclusion is only marginally significant (the significance level associated with p<sub>min</sub>, corrected for testing 15 sums, was p = 0.0577). Nonetheless, this result confirms an analogous conclusion based on the QQ plot. For the ten largest chi-square values, <a href="/pmc/articles/PMC2990809/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> also shows p-values based on permutation tests (pRand) but these values are close to those obtained by Bonferroni correction for multiple testing, which indicates that test results for the 279,911 SNPs are largely independent.</p><p id="P29">For the logistic regression controlling for age of death and sex, the genome-wide distribution of all SNPs and their regression p-values are presented in <a href="/pmc/articles/PMC2990809/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>. The ten SNPs with the lowest p-values for an association with the AD neuropathology phenotype are listed in <a href="/pmc/articles/PMC2990809/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>.Two of the three most significant SNPs, <em>rs4298437</em> and <em>rs6943822</em>, are in reelin (<em>RELN</em>); the p-value for <em>rs4298437</em> reached genome-wide significance with the conservative Bonferroni correction (p = .0162). Both reelin SNPs are located in the 5’end of the gene.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2990809/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923633680128" class="figure"><a href="/pmc/articles/PMC2990809/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2990809_nihms-222479-f0002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-222479-f0002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2990809/bin/nihms-222479-f0002.jpg"></a></div><div id="largeobj_idm139923633680128" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2990809/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2990809/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p3">Manhattan plot showing the distribution of analyzed SNPs and their corresponding genotypic association p-values from logistic regression. The SNPs are ordered by their positions on the chromosomes, and the chromosomes (number 1 to 22 from left to right) are alternately colored. The y axis is –log<sub>10</sub>(p-value).</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p8">Results of the genotype association test using logistic regression analysis with covariates, showing the 10 SNPs with the lowest p-values, in order of significance</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923635172080" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="center">Chr</th><th rowspan="1" colspan="1" valign="top" align="center">Position</th><th rowspan="1" colspan="1" valign="top" align="center">pNom<sup>1</sup></th><th rowspan="1" colspan="1" valign="top" align="center">pBon<sup>2</sup></th><th rowspan="1" colspan="1" valign="top" align="left">Gene<sup>3</sup></th><th rowspan="1" colspan="1" valign="top" align="left">Location</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs4298437</em>
<sup>*</sup>
</td><td rowspan="1" colspan="1" valign="top" align="center">7</td><td rowspan="1" colspan="1" valign="top" align="center">103413113</td><td rowspan="1" colspan="1" valign="top" align="center">5.86E-08</td><td rowspan="1" colspan="1" valign="top" align="center">0.0162</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>RELN</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">Intron</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs4784670</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center">55056012</td><td rowspan="1" colspan="1" valign="top" align="center">2.73E-07</td><td rowspan="1" colspan="1" valign="top" align="center">0.0764</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>OGFOD1</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">Intron</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs6943822</em>
<sup>*</sup>
</td><td rowspan="1" colspan="1" valign="top" align="center">7</td><td rowspan="1" colspan="1" valign="top" align="center">103385907</td><td rowspan="1" colspan="1" valign="top" align="center">2.80E-07</td><td rowspan="1" colspan="1" valign="top" align="center">0.0783</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>RELN</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">Intron</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs10498214</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center">227772424</td><td rowspan="1" colspan="1" valign="top" align="center">2.90E-07</td><td rowspan="1" colspan="1" valign="top" align="center">0.0812</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>COL4A3</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">Intron</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs2833546</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">21</td><td rowspan="1" colspan="1" valign="top" align="center">32170575</td><td rowspan="1" colspan="1" valign="top" align="center">3.94E-07</td><td rowspan="1" colspan="1" valign="top" align="center">0.1103</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>HUNK</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">Intron</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs11782819</em>
<sup>*</sup>
</td><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">10372191</td><td rowspan="1" colspan="1" valign="top" align="center">6.84E-07</td><td rowspan="1" colspan="1" valign="top" align="center">0.1914</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>UNQ9391</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">45 kb upstream</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs11649538</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center">24415618</td><td rowspan="1" colspan="1" valign="top" align="center">9.54E-07</td><td rowspan="1" colspan="1" valign="top" align="center">0.267</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>RBBP6</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">50 kb upstream</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs152745</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center">23273923</td><td rowspan="1" colspan="1" valign="top" align="center">1.02E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.2855</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>SCNN1B</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">Intron</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs4457311</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">125353540</td><td rowspan="1" colspan="1" valign="top" align="center">1.20E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.3359</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>LOC442396</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">Intron</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">
<em>rs11205449</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">1</td><td rowspan="1" colspan="1" valign="top" align="center">48419711</td><td rowspan="1" colspan="1" valign="top" align="center">1.38E-06</td><td rowspan="1" colspan="1" valign="top" align="center">0.3863</td><td rowspan="1" colspan="1" valign="top" align="left">
<em>SLC5A9</em>
</td><td rowspan="1" colspan="1" valign="top" align="left">40 kb upstream</td></tr></tbody></table></div><div id="largeobj_idm139923635172080" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2990809/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN7"><sup>*</sup>gene (in which SNP is located) appears also in the list of significant genes obtained in the allele association analysis (<a href="/pmc/articles/PMC2990809/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>)</div><div id="TFN8"><sup>1</sup>pNom = nominal p-value</div><div id="TFN9"><sup>2</sup>pBon = Bonferroni-corrected p-value (n = 279,911 SNPs)</div><div id="TFN10"><sup>3</sup>data from NCBI MapViewer Buuild 36.3 (<a href="http://www.ncbi.nlm.nih.gov/mapview/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/mapview/</a>)</div></div></div><p id="P30">In the post-hoc analysis both reelin SNPs showed highly significant allelic association with the phenotype, as shown in <a href="/pmc/articles/PMC2990809/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>. Alleles associated with the HIBraak group are the A allele of <em>rs4298437</em> (OR=2.51), and the A allele of <em>rs6943822</em> (OR=2.23).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p9">Results of post-hoc allelic association analysis of SNPs in <em>RELN</em></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923661200384" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="center">SNP</th><th rowspan="1" colspan="1" valign="top" align="center">Likelihood χ<sup>2</sup> p-value</th><th rowspan="1" colspan="1" valign="top" align="center">Freq Allele G</th><th rowspan="1" colspan="1" valign="top" align="center">Freq Allele G</th><th rowspan="1" colspan="1" valign="top" align="center">Freq Allele A</th><th rowspan="1" colspan="1" valign="top" align="center">Freq Allele B</th><th rowspan="1" colspan="1" valign="top" align="center">Odds Ratio</th><th rowspan="1" colspan="1" valign="top" align="center">95% CI</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">
<em>rs6943822</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.000</td><td rowspan="1" colspan="1" valign="top" align="center">0.33</td><td rowspan="1" colspan="1" valign="top" align="center">0.52</td><td rowspan="1" colspan="1" valign="top" align="center">0.67</td><td rowspan="1" colspan="1" valign="top" align="center">0.48</td><td rowspan="1" colspan="1" valign="top" align="center">2.23</td><td rowspan="1" colspan="1" valign="top" align="center">1.59 - 3.12</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">
<em>rs4298437</em>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.000</td><td rowspan="1" colspan="1" valign="top" align="center">0.54</td><td rowspan="1" colspan="1" valign="top" align="center">0.74</td><td rowspan="1" colspan="1" valign="top" align="center">0.46</td><td rowspan="1" colspan="1" valign="top" align="center">0.26</td><td rowspan="1" colspan="1" valign="top" align="center">2.51</td><td rowspan="1" colspan="1" valign="top" align="center">1.77 - 3.53</td></tr></tbody></table></div><div id="largeobj_idm139923661200384" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2990809/table/T4/?report=objectonly">Open in a separate window</a></div></div><p id="P31">The overlap between the results of the allelic association test and the logistic regression analysis was minimal; three of the most significant SNPs in the former were included among the most significant SNPs in the latter. We attribute two reasons to this apparent discrepancy. First, we incorporated age-at-death and sex as covariates in the logistic regression analysis, whereas the allele test was carried out without inclusion of covariates. Also, the allele test may be less powerful than the genotype test. In spite of these differences, the prominent feature of this analysis is that the <em>RELN</em> SNP <em>rs4298437</em> is the most significant SNP in both the allele and the genotype (with covariates) tests, with genome-wide significant Bonferroni-corrected p-values of .0341 and .0162, respectively; furthermore, in both tests, a second <em>RELN</em> SNP, <em>rs6943822</em>, is the third most significant SNP.</p><p id="P32">At the outset of this study, we excluded 101 subjects with mid-range (MED) Braak scores in order to maximize phenotypic differences between groups and avoid potential confounding effects of including subjects in this transitional category. Following the analysis, we examined the frequency of the <em>RELN</em> genotypes in <em>rs4298437</em> and <em>rs6943822</em> in this group of subjects. As indicated in <a href="/pmc/articles/PMC2990809/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span>Table 5</span></a>, frequencies for both SNPs in the MED Braak subjects were intermediate between those of the LO and HI Braak subjects. This substantiates our approach of using extreme phenotypes rather than introducing the potential confounding effect of choosing an arbitrary midrange value for dichotomizing groups.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="__p10">Frequencies(n, %) of <em>RELN</em>SNP genotypes in Braak score categories</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923632637472" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="middle" align="center">Genotype</th><th colspan="3" rowspan="1" valign="top" align="center">rs4298437</th></tr><tr><th rowspan="1" colspan="1" valign="top" align="center">LO Braak</th><th rowspan="1" colspan="1" valign="top" align="center">MED Braak</th><th rowspan="1" colspan="1" valign="top" align="center">HI Braak</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">AA</td><td rowspan="1" colspan="1" valign="top" align="center">10 (.05)</td><td rowspan="1" colspan="1" valign="top" align="center">10 (.10)</td><td rowspan="1" colspan="1" valign="top" align="center">25 (.18)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">AG</td><td rowspan="1" colspan="1" valign="top" align="center">81 (.41)</td><td rowspan="1" colspan="1" valign="top" align="center">49 (.48)</td><td rowspan="1" colspan="1" valign="top" align="center">74 (.52)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">GG</td><td rowspan="1" colspan="1" valign="top" align="center">105 (.54)</td><td rowspan="1" colspan="1" valign="top" align="center">42 (.42)</td><td rowspan="1" colspan="1" valign="top" align="center">42 (.30)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Total</td><td rowspan="1" colspan="1" valign="top" align="center">196</td><td rowspan="1" colspan="1" valign="top" align="center">101</td><td rowspan="1" colspan="1" valign="top" align="center">141</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center"></td><td colspan="3" rowspan="1" valign="top" align="center">
<strong><em>rs6943822</em></strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">AA</td><td rowspan="1" colspan="1" valign="top" align="center">47 (.24)</td><td rowspan="1" colspan="1" valign="top" align="center">29 (.28)</td><td rowspan="1" colspan="1" valign="top" align="center">54 (.38)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">AG</td><td rowspan="1" colspan="1" valign="top" align="center">95 (.48)</td><td rowspan="1" colspan="1" valign="top" align="center">48 (.48)</td><td rowspan="1" colspan="1" valign="top" align="center">73 (.52)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">GG</td><td rowspan="1" colspan="1" valign="top" align="center">54 (.28)</td><td rowspan="1" colspan="1" valign="top" align="center">24 (.24)</td><td rowspan="1" colspan="1" valign="top" align="center">14 (.10)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Total</td><td rowspan="1" colspan="1" valign="top" align="center">196</td><td rowspan="1" colspan="1" valign="top" align="center">101</td><td rowspan="1" colspan="1" valign="top" align="center">141</td></tr></tbody></table></div><div id="largeobj_idm139923632637472" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2990809/table/T5/?report=objectonly">Open in a separate window</a></div></div><p id="P33" class="p p-last">Despite differences in AD neuropathology, there was no significant difference between HI and LO Braak subjects with respect to the frequency of the <em>APOE</em>ε4 allele (<a href="/pmc/articles/PMC2990809/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). This lack of association between the ε4 allele and high levels of AD neuropathology may be related to the advanced age of these subjects (mean age at death in the HI Braak group = 87.8 years; <a href="/pmc/articles/PMC2990809/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). This would be consistent with a number of studies that suggest that the positive association between <em>APOE</em>ε4 and AD declines after the age of 85 years [<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851382">Juva, et al. 2000</a>]. In order to further validate this finding, we examined the frequency of <em>APOE</em>ε4 carriers (at least one ε4 allele) vs. non-carriers among the three genotypes for both <em>RELN</em> SNPs. As shown in <a href="/pmc/articles/PMC2990809/table/T6/" target="table" class="fig-table-link figpopup" rid-figpopup="T6" rid-ob="ob-T6" co-legend-rid=""><span>Table 6</span></a>, there were no significant differences in the frequency of ε4 carriers and non-carriers across SNP genotypes for <em>rs6943822</em> (p = .50) or <em>rs4298437</em> (p = .13).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T6"><h3>Table 6</h3><!--caption a7--><div class="caption"><p id="__p11">Relationship between <em>APOE</em> ε4 frequency and <em>RELN</em> genotypes</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923666615392" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="center">SNP <em>rs6943822</em> genotype<sup>*</sup></th><th rowspan="1" colspan="1" valign="top" align="center"># subjects w/ ≥ 1 ε4 allele</th><th rowspan="1" colspan="1" valign="top" align="center"># subjects w/ no ε4 allele</th><th rowspan="1" colspan="1" valign="top" align="center">SNP <em>rs4298437</em> genotype<sup>**</sup></th><th rowspan="1" colspan="1" valign="top" align="center"># subjects w/ ≥ 1 ε4 allele</th><th rowspan="1" colspan="1" valign="top" align="center"># subjects w/ no ε4 allele</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">GG</td><td rowspan="1" colspan="1" valign="top" align="center">10 (.15)</td><td rowspan="1" colspan="1" valign="top" align="center">51 (.21)</td><td rowspan="1" colspan="1" valign="top" align="center">GG</td><td rowspan="1" colspan="1" valign="top" align="center">23 (.35)</td><td rowspan="1" colspan="1" valign="top" align="center">110 (.46)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">AG</td><td rowspan="1" colspan="1" valign="top" align="center">35 (.52)</td><td rowspan="1" colspan="1" valign="top" align="center">114 (.48)</td><td rowspan="1" colspan="1" valign="top" align="center">AG</td><td rowspan="1" colspan="1" valign="top" align="center">33 (.49)</td><td rowspan="1" colspan="1" valign="top" align="center">105 (.44)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">AA</td><td rowspan="1" colspan="1" valign="top" align="center">22 (.33)</td><td rowspan="1" colspan="1" valign="top" align="center">73 (.31)</td><td rowspan="1" colspan="1" valign="top" align="center">AA</td><td rowspan="1" colspan="1" valign="top" align="center">11 (.16)</td><td rowspan="1" colspan="1" valign="top" align="center">23 (.10)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">total</td><td rowspan="1" colspan="1" valign="top" align="center">67</td><td rowspan="1" colspan="1" valign="top" align="center">238</td><td rowspan="1" colspan="1" valign="top" align="center">total</td><td rowspan="1" colspan="1" valign="top" align="center">67</td><td rowspan="1" colspan="1" valign="top" align="center">238</td></tr></tbody></table></div><div id="largeobj_idm139923666615392" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2990809/table/T6/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN11"><sup>*</sup>p = .50</div><div id="TFN12"><sup>**</sup>p = .13</div></div></div></div><div id="S16" class="sec sec-last"><h3 id="S16title">3.3 Reelin Immunohistochemistry</h3><p id="P34" class="p p-first">Reelin immunohistochemistry was performed on hippocampal sections from 19 (10 from the HI and 9 from the LO Braak group) subjects. Immunohistochemical staining for reelin was also performed on hippocampi from four subjects with clinical and neuropathological diagnoses of AD (Braak stage VI with moderate to frequent neuritic plaques). In general, reelin expression was confined to pyramidal neurons where it was present as variably intense cytoplasmic staining with highest expression in theCA2/3 sector of the hippocampus as previously described[<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851374">Martinez-Cerdeno, et al. 2002</a>]. Reelin expression tended to be very pronounced in AD with strong staining encountered especially in regions with many neurons undergoing granulovacuolar degeneration (GVD), a cytoplasmic feature associated with AD (<a href="/pmc/articles/PMC2990809/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>, top). Neurons with mild to moderate GVD in particular tended to have strong cytoplasmic reelin expression; granules and vacuoles themselves did not contain reelin and neurons with marked GVD tended to express less reelin due to extensive degeneration in general and to replacement of cytoplasmic with vacuolar lesions in particular. Reelin staining of neurofibrillary tangles and neuritic plaques was not conspicuous.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2990809/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923634619024" class="figure"><a href="/pmc/articles/PMC2990809/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2990809_nihms-222479-f0003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-222479-f0003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2990809/bin/nihms-222479-f0003.jpg"></a></div><div id="largeobj_idm139923634619024" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2990809/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2990809/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p4">Reelin expression in hippocampal pyramidal neurons. Hippocampal immunohistochemistry was performed on paraffin sections of hippocampus and representative pyramidal neurons from the CA2 region are depicted in AD (upper panel) and in non-demented subjects (lower panel). Strong cytoplasmic staining was noted in pyramidal neurons in AD, especially in regions in which significant granulovacuolar degeneration (GVD) was noted. Neuritic plaques and neurofibrillary tangles (NFTs) did not stain strongly for reelin. Cytoplasmic expression of reelin in pyramidal neurons was also present in non-demented subjects with HI Braak stages as defined in the text (lower right panel), similar to that observed in AD. Expression of reelin in LO Braak stages was less conspicuous (lower left panel).</p></div></div></div><p id="P35">In contrast, cognitively intact subjects in the LO Braak group tended to have lower reelin expression in the hippocampus , whereas reelin expression in the HI Braak group was similar to that observed in AD hippocampi. Hippocampal pyramidal neurons in both the LO and HI Braak groups displayed less GVD than in AD, but the tendency for increased reelin expression in the HI Braak group was still notable in neurons in which GVD was not present or was present to only a very limited extent (<a href="/pmc/articles/PMC2990809/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>, bottom).</p><p id="P36" class="p p-last">Total reelin expression was quantified as described in Methods. In both HI and LO Braak categories, subjects were stratified by two-SNP genotypes for <em>rs4298437</em> and <em>rs6943822</em>. Total hippocampal reelin expression was significantly reduced in the LO Braak group (p = 0.025; <a href="/pmc/articles/PMC2990809/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>). In addition, when the LO and HI Braak groups were combined, there was a suggestion of an association between GG homozygotes (for either or both reelin SNPs) and reduced reelin expression, although this trend did not reach statistical significance (p = 0.096).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC2990809/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139923630261680" class="figure"><a href="/pmc/articles/PMC2990809/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2990809_nihms-222479-f0004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-222479-f0004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2990809/bin/nihms-222479-f0004.jpg"></a></div><div id="largeobj_idm139923630261680" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2990809/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC2990809/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p5">Analysis of reelin expression in hippocampus. Immunohistochemical (IHC) expression of reelin was scored in the hippocampus of OHSU cases with postmortem interval less than 24 hours. Scores are the sum of semiquantitative assessments of cytoplasmic reelin positivity of pyramidal neurons in each sector as described in the text. Cases were stratified by Braak grouping and by genotype. Two-way ANOVA showed a significant association of reelin expression with HI vs. LO Braak stage (P=0.025) but no association with genotype.</p></div></div></div></div></div><div id="S17" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S17title">4. Discussion</h2><p id="P37" class="p p-first">We identified variants in the <em>RELN</em> gene that are significantly associated with AD neuropathology in cognitively healthy elderly individuals. Analysis of allelic association in two SNPs in <em>RELN</em> generated significant ORs, ranging from 2.23-2.51, for the alleles associated with the HIBraak category. A significant association with SNPs in <em>RELN</em> was also identified in a study of female AD patients [<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851369">Seripa, et al. 2008</a>]. The region of <em>RELN</em> we found associated with NFT pathology and the region found in <a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851363">Seripa et al (2008)</a> are both near promoter elements, which have been postulated to play a role in hypermethylation and therefore modification in expression of this gene [<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_806942292">Chin, et al. 2007</a>; <a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851377">Dong, et al. 2005</a>].</p><div id="S18" class="sec sec-last"><h3 id="S18title">4.1 Reelin</h3><p id="P38" class="p p-first">Reelin is an extracellular matrix glycoprotein, encoded by the <em>RELN</em> gene, which is secreted throughout the CNS and is important in neuronal development [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851376">Bar, et al. 2000</a>; <a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851364">D'Arcangelo 2006</a>].It is a ligand for at least three classes of cell membrane receptors involved in actin cytoskeleton regulation/reorganization and in tau phosphorylation. Tau is a microtubule-associated protein abundant in neurons and the primary component of NFTs. Normal reelin levels are necessary to prevent abnormal phosphorylation of tau [<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851368">Hiesberger, et al. 1999</a>; <a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851365">Ohkubo, et al. 2003</a>; <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851372">Trommsdorff, et al. 1999</a>]. Reelin is also associated with plaques in β-amyloid precursor protein/presenilin-1 double-transgenic mouse brains [<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851371">Wirths, et al. 2001</a>]. A recent report [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851370">Durakoglugil, et al. 2009</a>]indicates a role for reelin in protecting against beta-amyloid-induced suppression of long-term potentiation and NMDA receptors. Thus, reelin may play key roles in AD pathology both extracellularly with its involvement in plaques and intracellularly via inhibition of tau phosphorylation. Since tau phosphorylation is a key step in the formation of NFTs, our finding of an association between <em>RELN</em> polymorphisms and high levels of AD neuropathology is compelling. We note that the two <em>RELN</em> SNPs found to be associated with high levels of AD pathology in this study are probably not the actual functional SNPs in this regard, but instead are in strong linkage disequilibrium with other causative variants yet to be identified.</p><p id="P39">Evidence for direct involvement in pathways related to AD neuropathology is less apparent for other genes listed in <a href="/pmc/articles/PMC2990809/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Tables 2</span></a> and <a href="/pmc/articles/PMC2990809/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and3,</span></span><span>3</span></a>, with the exception of the histone deacetylase (HDAC) gene <em>HDAC4</em>. HDAC activities have been linked to neurodegenerative disorders [<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851366">Timmermann, et al. 2001</a>] and recently been shown to restore cognition in AD transgenic mice [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_234851383">Green, et al. 2008</a>]. Possible roles for a sodium/glucose transporter, <em>SLC5A9,</em> or a transmembrane protein, <em>TMEM65</em>, are also conceivable. Variants in these genes, or others represented in the tables, may function in as yet unknown ways to either prevent or promote the formation of NFTs and/or amyloid plaques.</p><p id="P40">Our discovery of increased expression of reelin in pyramidal neurons of the hippocampus in AD and in cognitively intact controls with AD-associated pathology suggests that up-regulation of reelin may be a compensatory response to β-amyloid or tau-related stress associated with AD even prior to the onset of dementia. If so, polymorphisms in <em>RELN</em> may influence the capacity for up-regulation in affected neuronal populations and thereby exert effects on cognitive reserve in the context of AD-associated stressors and pathologic lesions.</p><p id="P41">The purpose of this study was to identify genetic variants that distinguish cognitively healthy, elderly individuals with a heavy NFT burden from those with minimal NFT burden. The former group also had a significantly greater amyloid plaque burden than the latter. There are three broad mechanisms whereby genetic variants could mediate NFT burden in cognitively healthy individuals. They could act directly through pathways related to tau, indirectly through pathways related to β-amyloid pathology (which, in turn influences tau), or through other mechanisms that affect brain reserve (e.g., neuronal or synaptic plasticity). One interpretation of this study is that genetic variants in <em>RELN</em> result in perturbations associated with the development of NFTs (and amyloid plaques). Since these subjects were cognitively healthy, the implication is that other genetic variants and/or environmental factors are required for the development of cognitive dysfunction.</p><p id="P42">This is the first GWAS that specifically addresses genetic differences related to AD neuropathology in clinically non-demented elderly. This is important because these individuals are traditionally used as control subjects in case-control studies of AD, under the assumption that, as a group, they are free of genetic factors related to AD pathophysiology. If, as this analysis suggests, a proportion of clinically non-demented individuals harbor genetic variants that predispose them to the underlying neuropathology that characterizes AD, including them in a control group will likely confound the results of genetic case-control studies.</p><p id="P43" class="p p-last">These findings require replication in larger datasets with comparable phenotypes. Well-characterized, non-demented elderly with autopsy are difficult to obtain. The NIH is sponsoring the AD Genetics Consortium to assemble and analyze a comprehensive collection of AD cases and controls representing the collective resources of the AD research community. This collection will provide an outstanding opportunity for confirmation and expansion of the results reported here.</p></div></div><div id="S19" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">ACKNOWLEDGEMENTS</h2><div class="sec"><p id="__p1">The authors would like to thank the following individuals for their generous and varied contributions to the production of this report, including clinical and neuropathological data verification, DNA and brain tissue procurement and transportation, and data organization and transmission: Charles DeCarli MD, at the University of California at Davis; Marilyn Albert MD, at Johns Hopkins University; Christine Hulette MD, James Burke MD, Jeffrey Browndyke PhD, John Ervin, Michelle McCart and Mari Szmanski RN at Duke University Medical Center; Alison Goate PhD, at the Washington University School of Medicine; Joseph Parisi MD and Kris Johnson RN, at Mayo Clinic, Rochester, and Dennis Dixon at Mayo Clinic, Jacksonville; Sonya Anderson at the University of Kentucky; Mary Sundsmo at the University of California at San Diego; Eszter Gombosi at the University of Michigan; Jamie Laut at Oregon Health &amp; Science University. We thank Dr. Chungsheng He, Rockefeller University, for writing an R program to create the Manhattan plot.This work was supported by the National Institute on Aging (grants R01-AG026916, P30-AG028377, P50-AG005146, P30-AG028383, P50-AG16574, U01-AG06786, P30-AG008017, P30-AG10161, R01-AG17917, P30-AG10129, P50-AG05131, P50-AG08671, P50-AG05681, P01-AG03991, U01-<a id="__tag_806942293" class="tag_hotlink" href="/nuccore/AG016976" ref="/nuccore/AG016976"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AG016976","term_id":"55789945","term_text":"AG016976"}}</span>AG016976</a>) of the National Institutes of Health, and by the Natural Science Foundation of China NSFC, project number 30730057 (to JO).</p></div></div><div id="idm139923703215024" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139923703215024title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"></p><p id="P44" class="p p-first">DISCLOSURE STATEMENT</p><p id="P45" class="p p-last">Dr. Ronald Petersen serves as Chair of the Safety Monitoring Committee and consultant for Elan Pharmaceuticals, Chair of Safety Monitoring for Wyeth Pharmaceuticals and consultant for GE Healthcare.Dr. John Morris has participated or is currently participating in clinical trials of antidementia drugs sponsored by Elan Pharmaceuticals, Eli Lilly and Wyeth Pharmaceuticals. Dr. Morris has served as a consultant or has received speaking honoraria from AstraZeneca, Bristol-Myers Squibb, Genentech, Lilly, Merck, Novartis, Pfizer, Schering Plough, Wyeth, and Elan. Appropriate approval and procedures were used concerning human subjects.</p><p></p></div></div><div id="idm139923703212880" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139923703212880title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="R1"><span class="citation">Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. <span><span class="ref-journal">Neurobiol Aging. </span>1997;<span class="ref-vol">18</span>(4 Suppl):S1–2.</span> [<a href="/pubmed/9330978" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Aging&amp;title=Consensus+recommendations+for+the+postmortem+diagnosis+of+Alzheimer's+disease.+The+National+Institute+on+Aging,+and+Reagan+Institute+Working+Group+on+Diagnostic+Criteria+for+the+Neuropathological+Assessment+of+Alzheimer's+Disease.&amp;volume=18&amp;issue=4+Suppl&amp;publication_year=1997&amp;pages=S1-2&amp;pmid=9330978&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R2"><span class="citation">Bar I, Lambert de Rouvroit C, Goffinet AM. The evolution of cortical development. An hypothesis based on the role of the Reelin signaling pathway. <span><span class="ref-journal">Trends Neurosci. </span>2000;<span class="ref-vol">23</span>(12):633–8.</span> [<a href="/pubmed/11137154" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Neurosci&amp;title=The+evolution+of+cortical+development.+An+hypothesis+based+on+the+role+of+the+Reelin+signaling+pathway.&amp;author=I+Bar&amp;author=C+Lambert+de+Rouvroit&amp;author=AM+Goffinet&amp;volume=23&amp;issue=12&amp;publication_year=2000&amp;pages=633-8&amp;pmid=11137154&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R3"><span class="citation">Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>(5):834–41.</span> [<a href="/pubmed/15753419" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Mild+cognitive+impairment+is+related+to+Alzheimer+disease+pathology+and+cerebral+infarctions.&amp;author=DA+Bennett&amp;author=JA+Schneider&amp;author=JL+Bienias&amp;author=DA+Evans&amp;author=RS+Wilson&amp;volume=64&amp;issue=5&amp;publication_year=2005&amp;pages=834-41&amp;pmid=15753419&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R4"><span class="citation">Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. <span><span class="ref-journal">Acta Neuropathol. </span>1991;<span class="ref-vol">82</span>(4):239–59.</span> [<a href="/pubmed/1759558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Neuropathol&amp;title=Neuropathological+stageing+of+Alzheimer-related+changes.&amp;author=H+Braak&amp;author=E+Braak&amp;volume=82&amp;issue=4&amp;publication_year=1991&amp;pages=239-59&amp;pmid=1759558&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R5"><span class="citation">Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. <span><span class="ref-journal">J Neurosci. </span>2007;<span class="ref-vol">27</span>(11):2727–33.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6672562/">PMC free article</a>]</span> [<a href="/pubmed/17360894" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Reelin+depletion+in+the+entorhinal+cortex+of+human+amyloid+precursor+protein+transgenic+mice+and+humans+with+Alzheimer's+disease.&amp;author=J+Chin&amp;author=CM+Massaro&amp;author=JJ+Palop&amp;author=MT+Thwin&amp;author=GQ+Yu&amp;volume=27&amp;issue=11&amp;publication_year=2007&amp;pages=2727-33&amp;pmid=17360894&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R6"><span class="citation">D'Arcangelo G. Reelin mouse mutants as models of cortical development disorders. <span><span class="ref-journal">Epilepsy Behav. </span>2006;<span class="ref-vol">8</span>(1):81–90.</span> [<a href="/pubmed/16266828" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy+Behav&amp;title=Reelin+mouse+mutants+as+models+of+cortical+development+disorders.&amp;author=G+D'Arcangelo&amp;volume=8&amp;issue=1&amp;publication_year=2006&amp;pages=81-90&amp;pmid=16266828&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R7"><span class="citation">Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>(35):12578–83.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1194936/">PMC free article</a>]</span> [<a href="/pubmed/16113080" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Reelin+and+glutamic+acid+decarboxylase67+promoter+remodeling+in+an+epigenetic+methionine-induced+mouse+model+of+schizophrenia.&amp;author=E+Dong&amp;author=RC+Agis-Balboa&amp;author=MV+Simonini&amp;author=DR+Grayson&amp;author=E+Costa&amp;volume=102&amp;issue=35&amp;publication_year=2005&amp;pages=12578-83&amp;pmid=16113080&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R8"><span class="citation">Durakoglugil MS, Chen Y, White CL, Kavalali ET, Herz J. Reelin signaling antagonizes beta-amyloid at the synapse. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>(37):15938–43.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2747222/">PMC free article</a>]</span> [<a href="/pubmed/19805234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Reelin+signaling+antagonizes+beta-amyloid+at+the+synapse.&amp;author=MS+Durakoglugil&amp;author=Y+Chen&amp;author=CL+White&amp;author=ET+Kavalali&amp;author=J+Herz&amp;volume=106&amp;issue=37&amp;publication_year=2009&amp;pages=15938-43&amp;pmid=19805234&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R9"><span class="citation">Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, Leahy M, Montine T, Kaye J. Factors associated with resistance to dementia despite high Alzheimer disease pathology. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>(4):354–60.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2677499/">PMC free article</a>]</span> [<a href="/pubmed/19171833" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Factors+associated+with+resistance+to+dementia+despite+high+Alzheimer+disease+pathology.&amp;author=D+Erten-Lyons&amp;author=RL+Woltjer&amp;author=H+Dodge&amp;author=R+Nixon&amp;author=R+Vorobik&amp;volume=72&amp;issue=4&amp;publication_year=2009&amp;pages=354-60&amp;pmid=19171833&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R10"><span class="citation">Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. <span><span class="ref-journal">J Psychiatr Res. </span>1975;<span class="ref-vol">12</span>(3):189–98.</span> [<a href="/pubmed/1202204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Psychiatr+Res&amp;title=“Mini-mental+state”.+A+practical+method+for+grading+the+cognitive+state+of+patients+for+the+clinician.&amp;author=MF+Folstein&amp;author=SE+Folstein&amp;author=PR+McHugh&amp;volume=12&amp;issue=3&amp;publication_year=1975&amp;pages=189-98&amp;pmid=1202204&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R11"><span class="citation">Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. <span><span class="ref-journal">J Neurosci. </span>2008;<span class="ref-vol">28</span>(45):11500–10.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2617713/">PMC free article</a>]</span> [<a href="/pubmed/18987186" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Nicotinamide+restores+cognition+in+Alzheimer's+disease+transgenic+mice+via+a+mechanism+involving+sirtuin+inhibition+and+selective+reduction+of+Thr231-phosphotau.&amp;author=KN+Green&amp;author=JS+Steffan&amp;author=H+Martinez-Coria&amp;author=X+Sun&amp;author=SS+Schreiber&amp;volume=28&amp;issue=45&amp;publication_year=2008&amp;pages=11500-10&amp;pmid=18987186&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R12"><span class="citation">Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>(8):1119–22.</span> [<a href="/pubmed/12925369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Neurol&amp;title=Alzheimer+disease+in+the+US+population:+prevalence+estimates+using+the+2000+census.&amp;author=LE+Hebert&amp;author=PA+Scherr&amp;author=JL+Bienias&amp;author=DA+Bennett&amp;author=DA+Evans&amp;volume=60&amp;issue=8&amp;publication_year=2003&amp;pages=1119-22&amp;pmid=12925369&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R13"><span class="citation">Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. <span><span class="ref-journal">Neuron. </span>1999;<span class="ref-vol">24</span>(2):481–9.</span> [<a href="/pubmed/10571241" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Direct+binding+of+Reelin+to+VLDL+receptor+and+ApoE+receptor+2+induces+tyrosine+phosphorylation+of+disabled-1+and+modulates+tau+phosphorylation.&amp;author=T+Hiesberger&amp;author=M+Trommsdorff&amp;author=BW+Howell&amp;author=A+Goffinet&amp;author=MC+Mumby&amp;volume=24&amp;issue=2&amp;publication_year=1999&amp;pages=481-9&amp;pmid=10571241&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R14"><span class="citation">Hoh J, Wille A, Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. <span><span class="ref-journal">Genome Res. </span>2001;<span class="ref-vol">11</span>(12):2115–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC311222/">PMC free article</a>]</span> [<a href="/pubmed/11731502" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Trimming,+weighting,+and+grouping+SNPs+in+human+case-control+association+studies.&amp;author=J+Hoh&amp;author=A+Wille&amp;author=J+Ott&amp;volume=11&amp;issue=12&amp;publication_year=2001&amp;pages=2115-9&amp;pmid=11731502&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R15"><span class="citation">Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K, Sulkava R. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>(2):412–5.</span> [<a href="/pubmed/10668704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=APOE+epsilon4+does+not+predict+mortality,+cognitive+decline,+or+dementia+in+the+oldest+old.&amp;author=K+Juva&amp;author=A+Verkkoniemi&amp;author=P+Viramo&amp;author=T+Polvikoski&amp;author=K+Kainulainen&amp;volume=54&amp;issue=2&amp;publication_year=2000&amp;pages=412-5&amp;pmid=10668704&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R16"><span class="citation">Manly BFJ.  <span class="ref-journal">Randomization, bootstrap, and Monte Carlo methods in biology.</span> Chapman &amp; Hall/ CRC; Boca Raton, FL: 2007.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Randomization,+bootstrap,+and+Monte+Carlo+methods+in+biology&amp;author=BFJ+Manly&amp;publication_year=2007&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R17"><span class="citation">Martinez-Cerdeno V, Galazo MJ, Cavada C, Clasca F. Reelin immunoreactivity in the adult primate brain: intracellular localization in projecting and local circuit neurons of the cerebral cortex, hippocampus and subcortical regions. <span><span class="ref-journal">Cereb Cortex. </span>2002;<span class="ref-vol">12</span>(12):1298–311.</span> [<a href="/pubmed/12427680" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cereb+Cortex&amp;title=Reelin+immunoreactivity+in+the+adult+primate+brain:+intracellular+localization+in+projecting+and+local+circuit+neurons+of+the+cerebral+cortex,+hippocampus+and+subcortical+regions.&amp;author=V+Martinez-Cerdeno&amp;author=MJ+Galazo&amp;author=C+Cavada&amp;author=F+Clasca&amp;volume=12&amp;issue=12&amp;publication_year=2002&amp;pages=1298-311&amp;pmid=12427680&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R18"><span class="citation">Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. <span><span class="ref-journal">Neurology. </span>1993;<span class="ref-vol">43</span>(11):2412–4.</span> [<a href="/pubmed/8232972" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=The+Clinical+Dementia+Rating+(CDR):+current+version+and+scoring+rules.&amp;author=JC+Morris&amp;volume=43&amp;issue=11&amp;publication_year=1993&amp;pages=2412-4&amp;pmid=8232972&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R19"><span class="citation">Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, Sakanaka M, Tanaka J, Maeda N, Vitek MP. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. <span><span class="ref-journal">FASEB J. </span>2003;<span class="ref-vol">17</span>(2):295–7.</span> others. [<a href="/pubmed/12490540" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;title=Apolipoprotein+E+and+Reelin+ligands+modulate+tau+phosphorylation+through+an+apolipoprotein+E+receptor/disabled-1/glycogen+synthase+kinase-3beta+cascade.&amp;author=N+Ohkubo&amp;author=YD+Lee&amp;author=A+Morishima&amp;author=T+Terashima&amp;author=S+Kikkawa&amp;volume=17&amp;issue=2&amp;publication_year=2003&amp;pages=295-7&amp;pmid=12490540&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R20"><span class="citation">Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J, Pe'er I, Burtt NP, Blumenstiel B, DeFelice M. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>(12):1477–82.</span> others. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2652744/">PMC free article</a>]</span> [<a href="/pubmed/17982456" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Two+independent+alleles+at+6q23+associated+with+risk+of+rheumatoid+arthritis.&amp;author=RM+Plenge&amp;author=C+Cotsapas&amp;author=L+Davies&amp;author=AL+Price&amp;author=PI+de+Bakker&amp;volume=39&amp;issue=12&amp;publication_year=2007&amp;pages=1477-82&amp;pmid=17982456&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R21"><span class="citation">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ. PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>(3):559–75.</span> others. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses.&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;author=L+Thomas&amp;author=MA+Ferreira&amp;volume=81&amp;issue=3&amp;publication_year=2007&amp;pages=559-75&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R22"><span class="citation">Seripa D, Matera MG, Franceschi M, Daniele A, Bizzarro A, Rinaldi M, Panza F, Fazio VM, Gravina C, D'Onofrio G. The RELN locus in Alzheimer's disease. <span><span class="ref-journal">J Alzheimers Dis. </span>2008;<span class="ref-vol">14</span>(3):335–44.</span> others. [<a href="/pubmed/18599960" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Alzheimers+Dis&amp;title=The+RELN+locus+in+Alzheimer's+disease.&amp;author=D+Seripa&amp;author=MG+Matera&amp;author=M+Franceschi&amp;author=A+Daniele&amp;author=A+Bizzarro&amp;volume=14&amp;issue=3&amp;publication_year=2008&amp;pages=335-44&amp;pmid=18599960&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R23"><span class="citation">Timmermann S, Lehrmann H, Polesskaya A, Harel-Bellan A. Histone acetylation and disease. <span><span class="ref-journal">Cell Mol Life Sci. </span>2001;<span class="ref-vol">58</span>(5-6):728–36.</span> [<a href="/pubmed/11437234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Life+Sci&amp;title=Histone+acetylation+and+disease.&amp;author=S+Timmermann&amp;author=H+Lehrmann&amp;author=A+Polesskaya&amp;author=A+Harel-Bellan&amp;volume=58&amp;issue=5-6&amp;publication_year=2001&amp;pages=728-36&amp;pmid=11437234&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R24"><span class="citation">Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. <span><span class="ref-journal">Cell. </span>1999;<span class="ref-vol">97</span>(6):689–701.</span> [<a href="/pubmed/10380922" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Reeler/Disabled-like+disruption+of+neuronal+migration+in+knockout+mice+lacking+the+VLDL+receptor+and+ApoE+receptor+2.&amp;author=M+Trommsdorff&amp;author=M+Gotthardt&amp;author=T+Hiesberger&amp;author=J+Shelton&amp;author=W+Stockinger&amp;volume=97&amp;issue=6&amp;publication_year=1999&amp;pages=689-701&amp;pmid=10380922&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R25"><span class="citation">Whitlock MC. Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. <span><span class="ref-journal">J Evol Biol. </span>2005;<span class="ref-vol">18</span>(5):1368–73.</span> [<a href="/pubmed/16135132" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Evol+Biol&amp;title=Combining+probability+from+independent+tests:+the+weighted+Z-method+is+superior+to+Fisher's+approach.&amp;author=MC+Whitlock&amp;volume=18&amp;issue=5&amp;publication_year=2005&amp;pages=1368-73&amp;pmid=16135132&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R26"><span class="citation">Wirths O, Multhaup G, Czech C, Blanchard V, Tremp G, Pradier L, Beyreuther K, Bayer TA. Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. <span><span class="ref-journal">Neurosci Lett. </span>2001;<span class="ref-vol">316</span>(3):145–8.</span> [<a href="/pubmed/11744223" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;title=Reelin+in+plaques+of+beta-amyloid+precursor+protein+and+presenilin-1+double-transgenic+mice.&amp;author=O+Wirths&amp;author=G+Multhaup&amp;author=C+Czech&amp;author=V+Blanchard&amp;author=G+Tremp&amp;volume=316&amp;issue=3&amp;publication_year=2001&amp;pages=145-8&amp;pmid=11744223&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li></ul></div></div><div id="idm139923635445024" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139923635445024title">WEB References</h2><div class="ref-list-sec sec"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="R27"><span class="citation"> Plink, <a href="http://pngu.mgh.harvard.edu/~purcell/plink/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://pngu.mgh.harvard.edu/~purcell/plink/</a></span></li><li id="R28"><span class="citation"> R,  <a href="http://cran.cnr.berkeley.edu/web/packages/qvalue/index.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://cran.cnr.berkeley.edu/web/packages/qvalue/index.html</a>.</span></li><li id="R29"><span class="citation"> Sumstat, <a href="http://www.big.ac.cn/genemapping/sumstat.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.big.ac.cn/genemapping/sumstat.html</a>.</span></li><li id="R30"><span class="citation"><span></span> Systat,  <a href="http://www.systat.com/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.systat.com/</a> <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Systat,++http://www.systat.com/+" target="pmc_ext" ref="reftype=other&amp;article-id=2990809&amp;issue-id=191982&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li></ul></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm139923633529376title">Abstract</a></li><li><a href="#S1title">1. INTRODUCTION</a></li><li><a href="#S2title">2. Methods</a></li><li><a href="#S13title">3. Results</a></li><li><a href="#S17title">4. Discussion</a></li><li><a href="#S19title">ACKNOWLEDGEMENTS</a></li><li><a href="#idm139923703215024title">Footnotes</a></li><li><a href="#idm139923703212880title">References</a></li><li><a href="#idm139923635445024title">WEB References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2990809/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2990809/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2990809/pdf/nihms-222479.pdf">PDF (1.0M)</a></li> | <li><a href="#" data-citationid="PMC2990809" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2990809%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2990809%2F&amp;text=Alzheimer%20Disease%20Pathology%20in%20Cognitively%20Healthy%20Elderly%3AA%20Genome-wide%20Study" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2990809%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="20452100" data-aiid="2990809" data-aid="2990809" data-iid="191982" data-domainid="319" data-domain="nihpa" data-accid="PMC2990809" data-md5="952b35d976b7be15e94276dcc890a7e9"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T05:18:27-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8CD57ADD5066B10000000007A80527&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2990809%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2990809/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>